261 related articles for article (PubMed ID: 30657373)
1. Survival Disparities by Hospital Volume Among American Women With Gynecologic Cancers.
Seagle BL; Strohl AE; Dandapani M; Nieves-Neira W; Shahabi S
JCO Clin Cancer Inform; 2017 Nov; 1():1-15. PubMed ID: 30657373
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis.
Gibbs J; Mei S; Economos K; Lee YC; Kanis MJ
Am J Obstet Gynecol; 2019 Jul; 221(1):53.e1-53.e6. PubMed ID: 30849352
[TBL] [Abstract][Full Text] [Related]
3. Racial and ethnic disparities in palliative care utilization among gynecological cancer patients.
Islam JY; Deveaux A; Previs RA; Akinyemiju T
Gynecol Oncol; 2021 Feb; 160(2):469-476. PubMed ID: 33276985
[TBL] [Abstract][Full Text] [Related]
4. The impact of adjuvant vaginal brachytherapy in women with Stage II uterine endometrioid carcinoma: Results of a National Cancer Database analysis.
Lee JK; Ghanem AI; Modh A; Burmeister C; Mahmoud O; Maxwell GL; Elshaikh MA
Brachytherapy; 2018; 17(2):319-325. PubMed ID: 29174935
[TBL] [Abstract][Full Text] [Related]
5. Management for Elderly Women With Advanced-Stage, High-Grade Endometrial Cancer.
Rauh-Hain JA; Pepin KJ; Meyer LA; Clemmer JT; Lu KH; Rice LW; Uppal S; Schorge JO; Del Carmen MG
Obstet Gynecol; 2015 Dec; 126(6):1198-1206. PubMed ID: 26551187
[TBL] [Abstract][Full Text] [Related]
6. The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm.
Bristow RE; Palis BE; Chi DS; Cliby WA
Gynecol Oncol; 2010 Sep; 118(3):262-7. PubMed ID: 20573392
[TBL] [Abstract][Full Text] [Related]
7. Association between hospital treatment volume and survival of women with gynecologic malignancy in Japan: a JSOG tumor registry-based data extraction study.
Machida H; Matsuo K; Oba K; Aoki D; Enomoto T; Okamoto A; Katabuchi H; Nagase S; Mandai M; Yaegashi N; Yamagami W; Mikami M
J Gynecol Oncol; 2022 Jan; 33(1):e3. PubMed ID: 34783206
[TBL] [Abstract][Full Text] [Related]
8. Clinical statistics of gynecologic cancers in Japan.
Yamagami W; Nagase S; Takahashi F; Ino K; Hachisuga T; Aoki D; Katabuchi H
J Gynecol Oncol; 2017 Mar; 28(2):e32. PubMed ID: 28198168
[TBL] [Abstract][Full Text] [Related]
9. Trends in gynecologic cancer among elderly women in Denmark, 1980-2012.
Ør Knudsen A; Schledermann D; Nyvang GB; Mogensen O; Herrstedt J;
Acta Oncol; 2016; 55 Suppl 1():65-73. PubMed ID: 26784001
[TBL] [Abstract][Full Text] [Related]
10. Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology.
Yamagami W; Aoki D
J Obstet Gynaecol Res; 2015 Dec; 41(12):1861-9. PubMed ID: 26420746
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
[No Abstract] [Full Text] [Related]
12. Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; McKee B; Hoskins WJ; Barakat RR
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):79-85. PubMed ID: 12182977
[TBL] [Abstract][Full Text] [Related]
13. Disparities Associated With Inpatient Palliative Care Utilization by Patients With Metastatic Gynecologic Cancers: A Study of 3337 Women.
Rosenfeld EB; Chan JK; Gardner AB; Curry N; Delic L; Kapp DS
Am J Hosp Palliat Care; 2018 Apr; 35(4):697-703. PubMed ID: 29141457
[TBL] [Abstract][Full Text] [Related]
14. Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California.
Long B; Chang J; Ziogas A; Tewari KS; Anton-Culver H; Bristow RE
Am J Obstet Gynecol; 2015 Apr; 212(4):468.e1-9. PubMed ID: 25448522
[TBL] [Abstract][Full Text] [Related]
15. Brachytherapy Improves Survival in Stage III Endometrial Cancer With Cervical Involvement.
Bingham B; Orton A; Boothe D; Stoddard G; Huang YJ; Gaffney DK; Poppe MM
Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):1040-1050. PubMed ID: 28332987
[TBL] [Abstract][Full Text] [Related]
16. Survival after pelvic exenteration for uterine malignancy: A National Cancer Data Base study.
Seagle BL; Dayno M; Strohl AE; Graves S; Nieves-Neira W; Shahabi S
Gynecol Oncol; 2016 Dec; 143(3):472-478. PubMed ID: 27760707
[TBL] [Abstract][Full Text] [Related]
17. Survival impact of cytoreduction to microscopic disease for advanced stage cancer of the uterine corpus: a retrospective cohort study.
Alagkiozidis I; Grossman A; Tang NZ; Weedon J; Mize B; Salame G; Lee YC; Abulafia O
Int J Surg; 2015 Feb; 14():61-6. PubMed ID: 25576762
[TBL] [Abstract][Full Text] [Related]
18. Annual Report of the Committee on Gynecologic Oncology, Japan Society of Obstetrics and Gynecology: Patient Annual Report for 2013 and Treatment Annual Report for 2008.
Saito T; Katabuchi H
J Obstet Gynaecol Res; 2016 Sep; 42(9):1069-79. PubMed ID: 27338217
[TBL] [Abstract][Full Text] [Related]
19. Comparative Survival Outcomes of Uterine Papillary Serous Carcinoma, Clear Cell Carcinoma, Grade 3 Endometrioid Adenocarcinoma, and Carcinosarcoma of Endometrial Cancer in Rajavithi Hospital.
Prueksaritanond N; Chantape W
J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S75-83. PubMed ID: 27266220
[TBL] [Abstract][Full Text] [Related]
20. A clinical analysis of brain metastasis in gynecologic cancer: a retrospective multi-institute analysis.
Kim YZ; Kwon JH; Lim S
J Korean Med Sci; 2015 Jan; 30(1):66-73. PubMed ID: 25552885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]